European Healthtech startup funding raised during Q1 2020.
In Q1 2020, 90 European Healthtech companies raised a combined €917M across 90 funding rounds, up 13.0% versus Q1 2019. UK led by capital raised, and Kamet was the most active investor. Data as of 9 Jul 2026.
20 exits · €1.1B disclosed.
| Polyplus-Transfection | Acquisition | Feb 2020 | €460M |
| Galecto | Acquisition | Jan 2020 | €398M |
| MaSTherCell | Acquisition | Feb 2020 | €285M |
| €50M |
| K Health | Series C | Feb 2020 | €44M |
| Northsea Therapeutics | Series B | Jan 2020 | €36M |
| Evonetix | Series B | Feb 2020 | €27M |
| ŌURA | Series B | Mar 2020 | €25M |
| Merantix | Series A | Jan 2020 | €25M |
| Oncodna | Series B | Feb 2020 | €19M |
| Oviva | Series B | Jan 2020 | €19M |
| Citryll | Other | Feb 2020 | €19M |
| Alderaan Biotechnology | Series A | Jan 2020 | €19M |
| Geneuro | Other | Jan 2020 | €18M |
| Temedica | Series B | Jan 2020 | €17M |
